RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Collplant Biotechnologies - Stock

Collplant Biotechnologies Net Income 2024

Collplant Biotechnologies Net Income

-16.58 M USD

Collplant Biotechnologies Dividend yield

Ticker

CLGN

ISIN

US19516R1077

WKN

A2PMPX

In 2024, Collplant Biotechnologies's profit amounted to -16.58 M USD, a 136.28% increase from the -7.02 M USD profit recorded in the previous year.

The Collplant Biotechnologies Net Income history

YEARNET INCOME (undefined USD)
2026e-0.47
2025e25.23
2024e-16.58
2023-7.02
2022-16.93
20210.24
2020-5.77
2019-11.16
2018-6.25

Collplant Biotechnologies Aktienanalyse

What does Collplant Biotechnologies do?

CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Collplant Biotechnologies's Profit Margins

The profit margins of Collplant Biotechnologies represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Collplant Biotechnologies's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Collplant Biotechnologies's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Collplant Biotechnologies's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Collplant Biotechnologies’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Collplant Biotechnologies Stock

How much profit has Collplant Biotechnologies made this year?

Collplant Biotechnologies has made -16.58 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 136.28% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Collplant Biotechnologies publish its earnings?

Collplant Biotechnologies publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Collplant Biotechnologies?

The profits of Collplant Biotechnologies are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Collplant Biotechnologies?

You can learn more about the earnings of Collplant Biotechnologies by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Collplant Biotechnologies pay?

Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Collplant Biotechnologies?

The current dividend yield of Collplant Biotechnologies is .

When does Collplant Biotechnologies pay dividends?

Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collplant Biotechnologies?

Collplant Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Collplant Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collplant Biotechnologies located?

Collplant Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collplant Biotechnologies from 6/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/9/2024.

When did Collplant Biotechnologies pay the last dividend?

The last dividend was paid out on 6/9/2024.

What was the dividend of Collplant Biotechnologies in the year 2023?

In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.

In which currency does Collplant Biotechnologies pay out the dividend?

The dividends of Collplant Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Collplant Biotechnologies

Our stock analysis for Collplant Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collplant Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.